Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment
Yufeng Wang, David L. Drum, Ruochuan Sun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Targeting cuproplasia and cuproptosis in cancer
Daolin Tang, Guido Kroemer, Rui Kang
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 5, pp. 370-388
Closed Access | Times Cited: 122
A cuproptosis-based nanomedicine suppresses triple negative breast cancers by regulating tumor microenvironment and eliminating cancer stem cells
Chen Xiao, Xing Wang, Shiyou Li, et al.
Biomaterials (2024) Vol. 313, pp. 122763-122763
Closed Access | Times Cited: 21
Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells
Wei Guo, Lin Jia, Ling Xie, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 10
B7-H3 CAR-T cell therapy combined with irradiation is effective in targeting bulk and radiation-resistant chordoma cancer cells
Kun Wang, David O. Osei-Hwedieh, Tara Walhart, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e009544-e009544
Open Access | Times Cited: 1
Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing
Rama Rao Malla, V Sathiyapriya, Sree Makena, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1463-1463
Open Access | Times Cited: 8
<SPAN style="font-size: 11.0pt; font-family: 'Arial',sans-serif;">Chimeric Antigen Receptor T Cell with an Inducible Caspase 9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting</SPAN>
Marco Ventin, Giulia Cattaneo, Shahrzad Arya, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 15, pp. 3243-3258
Closed Access | Times Cited: 8
Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
Yun Chang, Ming‐Yang Chang, Xiaoping Bao, et al.
Bioactive Materials (2024) Vol. 42, pp. 379-403
Open Access | Times Cited: 7
Disulfiram/Copper Activates ER Stress to Promote Immunogenic Cell Death of Oral Squamous Cell Carcinoma
Yanjuan Zhao, Bo Zhao, Shujin Zhu
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 1291-1298
Closed Access | Times Cited: 5
The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma
Anup Singh Pathania, Haritha Chava, Nagendra K. Chaturvedi, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 5
Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy
Sai‐Nan Zhang, Qibo Huang, Tuo Ji, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy
Marco Ventin, Giulia Cattaneo, Luke Maggs, et al.
JAMA Oncology (2023) Vol. 10, Iss. 1, pp. 115-115
Closed Access | Times Cited: 12
YX0798 Is a Highly Potent, Selective, and Orally Effective CDK9 Inhibitor for Treating Aggressive Lymphoma
Changying Jiang, Yu Xue, Hong Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, et al.
Cancer Immunology Research (2025) Vol. 13, Iss. 2, pp. 210-228
Closed Access
Cuproptosis Nanoprodrug-Initiated Self-Promoted Cascade Reactions for Postoperative Tumor Therapy
Ruirui Yan, Xuan Cheng, Yujing Song, et al.
Biomaterials (2025) Vol. 318, pp. 123176-123176
Closed Access
Metal-based immunogenic cell death inducers for cancer immunotherapy
Jun Zou, Meng Rui Chang, Nikita A. Kuznetsov, et al.
Chemical Science (2025)
Open Access
Bioengineering the metabolic network of CAR T cells with GLP-1 and Urolithin A increases persistence and long-term anti-tumor activity
Areej Akhtar, Md Shakir, Mohammed Saleh Al Ansari, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 3, pp. 102021-102021
Open Access
Exploring the role of LOX family in glioma progression and immune modulation
Chen Liu, Huilian Qiao, Hongqi Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges
Hinrich Abken
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access
CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives
Rebecca Epperly, Stephen Gottschalk, Christopher DeRenzo
EJC Paediatric Oncology (2024) Vol. 3, pp. 100160-100160
Open Access | Times Cited: 3
Regulation of anti-tumor immunity by metal ion in the tumor microenvironment
Yaoxin Gao, Shasha Liu, Yifan Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Unlocking the potential of chimeric antigen receptor T cell engineering immunotherapy: Long road to achieve precise targeted therapy for hepatobiliary pancreatic cancers
Hongli Gao, Lianyue Qu, Mu Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 297, pp. 139829-139829
Closed Access
Chromosomal instability: a key driver in glioma pathogenesis and progression
Adele Mazzoleni, Wireko Andrew Awuah, Vivek Sanker, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 5
A Review of CAR-T Combination Therapies for Treatment of Gynecological Cancers
Valentina Olifirenko, Nikolai A. Barlev
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6595-6595
Open Access | Times Cited: 1
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond
Surya Pandey, Meghan E. Cholak, Rishita Yadali, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 475-475
Open Access
Page 1 - Next Page

Scroll to top